MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-20-0000248
Verlen Labs Private Limited
Verlen Labs Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.01 Cr
▼ 18% YoY
Net profit · FY 2024
₹1.62 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹2.6 Lakh
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹97 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Verlen Labs Private Limited
Data last updated:
Verlen Labs Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2016PTC111560. Its GSTIN is 37AAFCV6480P1ZG (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tripura Sundari Borra (Managing Director) and Borra Udayabaskar.
Its last annual general meeting (AGM) was held on 23 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.01 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 0.4%) and EBITDA of ₹2.6 Lakh (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 42% over five years.
As per MCA filings, the company has open charges of ₹97 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Verlen Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-20-0000248). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2016PTC111560
Registration Number 111560
Incorporation Date 22 August 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 December 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AP-20-0000248
Recognitions & Rankings of Verlen Labs
Contact details
Verlen Labs Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address7 – 1 – 136 137 138/A 138/B First Floor Portion B, Bandimet Begumpet Marredpally Hyderabad, Secunderabad, Telangana, India – 500003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Verlen Labs Private Limited, buy the company report.
Comprehensive company report
Verlen Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Verlen Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Verlen Labs Private Limited, buy the company report.
Financials of Verlen Labs Private Limited
FY 2024 filings availableVerlen Labs Private Limited reported revenue of ₹4.01 Cr (down 18% YoY) for FY 2024.
Revenue · FY 2024
₹4.01 Cr ▼ 18%
Net profit · FY 2024
₹1.62 Lakh margin 0.4%
EBITDA · FY 2024
₹2.6 Lakh margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 18%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 17%
5 years · compounded
▲ 14%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Verlen Labs Private Limited, buy the company report.
Board of directors of Verlen Labs Private Limited
Verlen Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tripura Sundari Borra | Managing Director | 10 Jul 2017 | 9 Years 3 Months | Current |
| Borra Udayabaskar Also directs: Ekard Life Sciences Private Limited | Director | 22 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Verlen Labs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srisukipharma Private Limited | ₹4.02 Cr (FY 2024) | 79.0% | Vellore, Tamil Nadu, India | |||
| Ezyspit Solutions Private Limited | ₹4.02 Cr (FY 2022) | 1429.0% | Maratha Hotel Nagpur, Maharashtra, India | |||
| Algen Remedies Private Limited | ₹4.01 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Verlen Labs Private Limitedthis company | ₹4.01 Cr (FY 2024) | ₹1.62 Lakh | 0.4% | -18.0% | Secunderabad, Telangana, India | |
| Amraph India Private Limited | ₹4.01 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India | |||
| Cure Quick Remedies Private Limited | ₹4 Cr (FY 2025) | -42.0% | Haryana, India | |||
| Astraazin Pharmaceuticals Private Limited | ₹4 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India | |||
| Aslan Healthcare Private Limited | ₹3.99 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Verlen Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹97 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2022 | 100582747 | Axis Bank Limited | ₹97 Lakh | Open |
To see the full charge records of Verlen Labs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Verlen Labs Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Protium Finance Limited | Pending |
| High Court of Rajasthan | Writ petition | Filed against the company by M/S. Wonset Healthcare Pvt. Ltd | Disposed |
To see the full case history of Verlen Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Verlen Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Verlen Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCV6480P1ZG | Andhra Pradesh | Active | 13 Apr 2018 |
To see the full GST registrations and return filing status of Verlen Labs Private Limited, buy the company report.
Recent activity
Verlen Labs Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Pamuluyadav Bandaru ceased to be Director on 18 Jul 2017.
AGM
Verlen Labs Private Limited last Annual general meeting of members was held on 23 Dec 2024 as per latest MCA records.
Filing
Verlen Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 97.00 Lakh registered on 30 May 2022 with Charge ID 100582747 was modified on 21 Jun 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 97.00 Lakh with Charge ID 100582747 was registered on 30 May 2022.
Ceased
Pamuluyadav Bandaru ceased to be Director.
Appointed
Tripura Sundari Borra was appointed as Managing Director.
Appointed
Borra Udayabaskar was appointed as Director.
Incorporation
22 Aug 2016
Verlen Labs Private Limited was registered on 22 Aug 2016 with Roc Hyderabad & aged 10 years 2 months as per MCA records.
Frequently asked questions
Verlen Labs is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2016 (10+ years old) and is registered under CIN U24100TG2016PTC111560.
Verlen Labs has 2 current directors:
- Tripura Sundari Borra - Managing Director
- Borra Udayabaskar - Director
The latest financial statements of Verlen Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 23 December 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Verlen Labs is 37AAFCV6480P1ZG, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Verlen Labs is U24100TG2016PTC111560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Verlen Labs has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Verlen Labs was incorporated on 22 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Verlen Labs by revenue are Srisukipharma Private Limited, Ezyspit Solutions Private Limited, Algen Remedies Private Limited, Amraph India Private Limited, Chiron Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pamuluyadav Bandaru ceased to be Director on 18 Jul 2017. Tripura Sundari Borra was appointed as Managing Director on 10 Jul 2017. Borra Udayabaskar was appointed as Director on 22 Aug 2016.
Yes, Verlen Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-20-0000248).
The registered office of Verlen Labs is at 7 – 1 – 136 137 138A 138B First Floor Portion B, Bandimet Begumpet Marredpally Hyderabad, Secunderabad, Telangana, India – 500003.